Effects of omega-3 fatty acids and/or antioxidants on endothelial cell markers

European Journal of Clinical Investigation

Volumn 28, Issue 8, 1998, Pages 629-635

  Seljeflot, I ^a   Arnesen, H ^a   Brude, I R ^b   Nenseter, M S ^b   Drevon, C A ^b   Hjermann, I ^a  

^a ULLEVÅL UNIVERSITY HOSPITAL   (Norway)

^b UNIVERSITY OF OSLO   (Norway)

Author keywords

Antioxidants; Endothelial function; Hyperlipidaemia; Omega 3 fatty acids

Indexed keywords

ALPHA TOCOPHEROL; ANTIOXIDANT; ASCORBIC ACID; BETA CAROTENE; CELL ADHESION MOLECULE; ENDOTHELIAL LEUKOCYTE ADHESION MOLECULE 1; OMEGA 3 FATTY ACID; PADGEM PROTEIN; THROMBOMODULIN; VASCULAR CELL ADHESION MOLECULE 1; VON WILLEBRAND FACTOR;

ADULT; ARTICLE; CHOLESTEROL BLOOD LEVEL; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG EFFECT; ENDOTHELIUM INJURY; HUMAN; HYPERLIPIDEMIA; MALE; ORAL DRUG ADMINISTRATION; PHOSPHOLIPID BLOOD LEVEL; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; VASCULAR ENDOTHELIUM;

EID: 0031821452     PISSN: 00142972     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2362.1998.00336.x     Document Type: Article

References (53)

1. Ross R. The pathogenesis of atherosclerosis: a perspective for the 1990s. Nature 1993; 362: 801-9.
2. Vita JA, Treasure CB, Nabel EG, et al. Coronary vasomotor response to acetylcholin relates to risk factors for coronary artery disease. Circulation 1990; 81: 491-7.
3. Henry PD, Cabello OA, Chen CH. Hypercholesterolemia and endothelial dysfunction. Current Opinion Lipidol 1995; 6: 190-5.
4. Børsum T. Biochemical properties of vascular endothelial cells. Virchows Arch B Cell Pathol 1991; 60: 279-86.
5. Steinberg D, Parthasarathy S, Carew TE, Khoo JC, Witztum JL. Beyond cholesterol: modifications of low-density lipoprotein that increase its atherogenicity. N Engl J Med 1989; 320: 915-24.
6. Moncada S, Higgs A. The L-arginine-nitric oxide pathway. N Engl J Med 1993; 329: 2002-12.
7. Liao W. Endotoxin: Possible roles in initiation and development of atherosclerosis. J Lab Clin Med 1996; 128: 452-60.
8. Davies MJ, Gordon JL, Gearing AJH, et al. The expression of the adhesion molecules ICAM-1, VCAM-1, PECAM, and E-selectin in human atherosclerosis. J Pathol 1993; 171: 223-9.
9. O'Brien KD, McDonald TO, Chait A, Allen MD, Alpers CE. Neovascular expression of E-selectin, intercellular adhesion molecule-1, and vascular cell adhesion molecule-1 in human atherosclerosis and their relation to intimal leukocyte content. Circulation 1996; 93: 672-82.
10. Blann AD, Collum CN. Circulating endothelial cell/leucocyte adhesion molecules in atherosclerosis. Thromb Haemost 1994; 72: 151-4.
11. Fassbender K, Mössner R, Motsch L, Kischka U, Grau A, Hennerici M. Circulating selectin- and immunoglobulin-type adhesion molecules in acute ischemic stroke. Stroke 1995; 26: 1361-4.
12. Hackman A, Abe Y, Insull W, et al. Levels of soluble cell adhesion molecules in patients with dyslipidemia. Circulation 1996; 93: 1334-8.
13. Seigneur M, Duforcq P, Conri C, et al. Levels of plasma thrombomodulin are increased in atheromatous arterial disease. Thromb Res 1993; 71: 423-31.
14. Badimon L, Badimon JJ, Chesebro JH, Fuster V. von Willebrand factor and cardiovascular disease. Thromb Haemost 1993; 70: 111-8.
15. Ridker PM, Vaughan DE, Stampfer MJ, Manson J, Hennekens CH. Endogenous tissue-type plasminogen activator and risk of myocardial infarction. Lancet 1993; 341: 1165-8.
16. van Boven AJ, Jukema JW, Paoletti R. Endothelial dysfunction and dyslipidemia: Possible effects of lipid lowering and lipid modifying therapy. Pharmacol Res 1994; 29: 261-72.
17. Celermajer DSS, Ørensen KE, Georgakopoulos D, et al. Cigarette smoking is associated with dose-related and potentially reversible impairment of endothelium-dependent dilation in healthy young adults. Circulation 1993; 88 (Part 1): 2149-55.
18. Heinzer T, Ylä-Herttuala S, Luoma J, et al. Cigarette smoking potentiates endothelial dysfunction of forearm resistance vessels in patients with hypercholesterolemia. Role oxidized LDL Circulation 1996; 93: 1346-53.
19. Weber C, Erl W, Weber K, Weber P. Increased adhesiveness of isolated monocytes to endothelium is prevented by vitamin C intake in smokers. Circulation 1996; 93: 1488-92.
20. Treasure CB, Klein JL, Weinstraub WS, et al. Beneficial effect of cholesterol-lowering therapy on the coronary endothelium in patients with coronary artery disease. N Engl J Med 1995; 332: 481-7.
21. Anderson TJ, Meredith IT, Yeung AC, Frei B, Selwyn AP, Ganz P. The effect of cholesterol-lowering and antioxidant therapy on endothelium-dependent coronary vasomotion. N Engl J Med 1995; 332: 488-93.
22. Olsson AG, Yuan XM. Antioxidants in the prevention of atherosclerosis. Current Opinion Lipodol 1996; 7: 374-80.
23. Hennekens CH, Buring JE, Manson JE, et al. Lack of effect of long-term supplementation with beta carotene on the incidence of malignant neoplasms and cardiovascular disease. N Engl J Med 1996; 334: 1145-9.
24. Kinsella JE. Effects of polyunsaturated fatty acids on factors related to cardiovascular disease. Am J Cardiol 1987; 60: 23G-32G.
25. Leaf A, Weber PC. Cardiovascular effects of n-3 fatty acids. N Engl J Med 1988; 318: 549-57.
26. Eritstand J, Arnesen H, Grønseth K, Fjeld NB, Abdelnoor M. Effect of supplementation with n-3 fatty acids on coronary artery bypass graft patency. Am J Cardiol 1996; 77: 31-8.
27. Harris WS. Fish oils and plasma lipid and lipoprotein metabolism in humans: a critical review. J Lipid Res 1989; 30: 785-806.
28. Bønaa KH, Bjerve KS, Straume B, Gram IT, Thelle D. Effects of eicosapentaenoic and docosahexaenoic acids on blood pressure in hypertension. N Engl J Med 1990; 322: 795-801.
29. Kristensen SD, Schmidt EB, Dyerberg J. Dietary supplementation with n-3 polyunsaturated fatty acids and human platelet function: a review with particular emphasis on implications for cardiovascular disease. J Intern Med 1989; 225: 141-50.
30. Muller AD, van Houwelingen AC, van Dam-Mieras MCE, Bas MB, Hornstra G. Effect of a moderate fish intake on haemostatic parameters in healthy males. Thromb Haemost 1989; 61: 468-73.
31. Emeis JJ, van Houwelingen AC, van den Hoogen CM, Hornstra G. A moderate fish intake increases plasminogen activator inhibitor type-1 in human volunteers. Blood 1989; 74: 233-7.
32. Eritstand J, Arnesen H, Seljeflot I, Kierulf P. Long-term effect of n-3 polyunsaturated fatty acids on haemostatic variables and bleeding episodes in patients with coronary artery disease. Blood Coagulation Fibrinolysis 1995; 6: 17-22.
33. Shimokawa H, Vanhoutte PM. Dietary cod-liver oil improves endothelium-dependent responses in hypercholesterolemic and atherosclerotic porcine coronary arteries. Circulation 1988; 78: 1421-30.
34. Andreassen AK, Hartmann A, Offstad J, Geiran O, Kvernebo K, Simonsen S. Hypertension prophylaxis with omega-3 fatty acids in heart transplant recipients. J Am Coll Cardiol 1997; 29: 1324-31.
35. De Caterina R, Cybulsky M, Clinton SK, Gimbrone MA, Libby P. The omega-3 fatty acid docosahexaenoate reduces cytokine-induced expression of proatherogenic and proinflammatory proteins in human endothelial cells. Arterioscler Thromb 1994; 14: 1829-36.
36. Harats D, Dabach Y, Hollander G, et al. Fish oil ingestion in smokers and nonsmokers enhances peroxidation of plasma lipoproteins. Atherosclerosis 1991; 90: 127-39.
37. Brude IR, Drevon CA, Hjermann I, et al. Peroxidation of low density lipoprotein from male smokers with combined hyperlipidemia supplied with omega-3 fatty acids and antioxidants. Arterioscler Thromb Vasc Biol 1997; 17: 2576-88.
38. Dean AG, Dean JA, Burton AH, Dicker RC. Epi Info, Version 5. Stone Mountain, GA, USA: USD 1990.
39. Hau MF, Smelt AHM, Bindels AJGH, et al. Effects of fish oil oxidation resistance of VLDL in hypertriglyceridemic patients. Arterioscler Thromb Vasc Biol 1996; 16: 1197-202.
40. Nenseter MS, Rustan AC, Lund-Katz S, et al. Effects of dietary supplementation with n-3 polyunsaturated fatty acids on physical properties and metabolism of low density lipoprotein in humans. Arterioscler Thromb 1992; 12: 369-79.
41. Lussier-Cacan S, Dubreuil-Quidoz S, Roederer G, et al. Influence of probucol on enhanced LDL oxidation after fish oil treatment of hypertriglyceridemic patients. Arterioscler Thromb 1993; 13: 1790-7.
42. Bonanome A. Biasia F, De Luca M, et al. n-3 fatty acids do not enhance LDL susceptibility to oxidation in hypertriacylglycerolemic hemodialyzed subjects. Am J Clin Nutr 1996; 63: 261-6.
43. Blann A, Seigneur M. Endothelial cell markers in peripheral disease and vascular surgery. Crit Ischaemia 1996; 6: 87-95.
44. Dahlbäck B. Physiological anticoagulation. Resistance to activated protein C and venous thromboembolism. J Clin Invest 1994; 94: 923-7.
45. Nesheim M, Wang W, Boffa M, Nagashima M, Morser J, Bajzar L. Thrombin, thrombomodulin and TAFI in the molecular link between coagulation and fibrinolysis. Thromb Haemost 1997; 78: 386-91.
46. Endres S, von Schacky C. n-3 polyunsaturated fatty acids and human cytokine synthesis. Curr Opin Lipidol 1996; 7: 8-13.
47. Fijnheer R, Frijns JM, Korteweg J, et al. The origin of P-selectin as a circulating plasma protein. Thromb Haemost 1997; 77: 1081-5.
48. Marui N, Offermann MK, Swerlick R, et al. Vascular cell adhesion molecule-1 (VCAM-1) gene transcription and expression are regulated through an antioxidant-sensitive mechanism in human vascular endothelial cells. J Clin Invest 1993; 92: 1866-74.
49. Barnes PJ, Karin M. Nuclear factor-κB - A pivotal transcription factor in chronic inflammatory diseases. N Engl J Med 1997; 336: 1066-71.
50. Collins T. Biology of disease: endothelial nuclear factor-κB and the initiation of the atherosclerotic lesion. Lab Invest 1993; 68: 499-508.
51. Frostegaard J, Wu R, Haegerstrand A, Pataaoyo M, Lefvert AK, Nilsson J. Mononuclear leukocytes exposed to oxidized low density lipoprotein secrete a factor that stimulates endothelial cells to express adhesion molecules. Atherosclerosis 1993; 103: 213-9.
52. Oostenbrug GS, Mensink RP, Hornstra G. Effects of fish oil and vitamin E supplementation on copper-catalysed oxidation of human low density lipoprotein in vitro. Eur J Clin Nutr 1994; 48: 895-8.
53. Weber C, Erl W, Pietch A, Strobel M, Ziegler-Heitbrock HWL, Weber PC. Antioxidants inhibit monocyte adhesion by suppressing nuclear factor-κB mobilization and induction of vascular cell adhesion molecule-1 in endothelial cells stimulated to generate radicals. Arterioscler Thromb 1994; 14: 1665-73.